Genotyping for epidemiology studies

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Abstract

The Core Genotyping Facility (CGF) was established to investigate the contribution of germline genetic variation to cancer susceptibility and outcomes. Working in concert with epidemiologists, biostatisticians and basic research scientists in the intramural research program, the CGF developed the capacity to conduct genome-wide association studies (GWAS) and candidate gene approaches to identify the heritable determinants of various forms of cancer. The CGF offers a wide variety of genotyping operations and has recently expanded to include next-generation sequencing technologies for follow-up of regions identified by GWAS. In addition to offering the latest in genomics technology, the CGF has a fully integrated Laboratory Information Management System (LIMS), comprehensive project management, quality control, and bioinformatics and analytic capabilities, making it a unique collaborative center for NCI-driven scientific endeavors.